| Dr Michael Ryan Casner, MD, MA | |
|
800 W Central Rd, Arlington Heights, IL 60005-2349 | |
| (847) 618-3040 | |
| Not Available |
| Full Name | Dr Michael Ryan Casner |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 11 Years |
| Location | 800 W Central Rd, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093058190 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mt Sinai Hospital Medical Center | Chicago, IL | Hospital |
| Holy Cross Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cepamerica Illinois Llp | 3274793633 | 407 |
News Archive
We commend the Senate Finance Committee for the work they have put into developing an equitable and affordable approach to making health care coverage accessible to the millions of Americans who do not now have it.
A study led by Dr Mark Ashworth, Dr Maria Kordowicz and Professor Judith Green, School of Population Health & Environmental Sciences, reveals the complex reasons that patients develop multiple, long-term conditions in urban areas.
The European Society for Medical Oncology is proud to announce that it has formally recognized 27 cancer centers for their commitment to providing excellent palliative care as part of the care they offer to patients.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
| Entity Name | Cepamerica Illinois Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912283110 PECOS PAC ID: 3274793633 Enrollment ID: O20120322000587 |
News Archive
We commend the Senate Finance Committee for the work they have put into developing an equitable and affordable approach to making health care coverage accessible to the millions of Americans who do not now have it.
A study led by Dr Mark Ashworth, Dr Maria Kordowicz and Professor Judith Green, School of Population Health & Environmental Sciences, reveals the complex reasons that patients develop multiple, long-term conditions in urban areas.
The European Society for Medical Oncology is proud to announce that it has formally recognized 27 cancer centers for their commitment to providing excellent palliative care as part of the care they offer to patients.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Ryan Casner, MD, MA 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (847) 618-3040 | Dr Michael Ryan Casner, MD, MA 800 W Central Rd, Arlington Heights, IL 60005-2349 Ph: (847) 618-3040 |
News Archive
We commend the Senate Finance Committee for the work they have put into developing an equitable and affordable approach to making health care coverage accessible to the millions of Americans who do not now have it.
A study led by Dr Mark Ashworth, Dr Maria Kordowicz and Professor Judith Green, School of Population Health & Environmental Sciences, reveals the complex reasons that patients develop multiple, long-term conditions in urban areas.
The European Society for Medical Oncology is proud to announce that it has formally recognized 27 cancer centers for their commitment to providing excellent palliative care as part of the care they offer to patients.
AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its INFINITI® CYP2C19 Assay. The test detects 3 genetic variants, *2, *3, *17, of the CYP450 2C19 gene and is to be used on the company's automated molecular testing platform, the INFINITI® Analyzer.
› Verified 9 days ago
John A Shanley, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-4177 | |
Charles Nozicka, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 800 W Central Rd, Northwest Community Hospital, Arlington Heights, IL 60005 Phone: 847-618-2494 | |
Dr. Carl Boyar, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1835 W Central Rd, Arlington Heights, IL 60005 Phone: 847-385-5022 | |
Dr. Michael Edward Donahue, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W. Central Rd., Arlington Heights, IL 60005 Phone: 847-618-3040 | |
Dr. Rubeal Singh Mann, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 800 W Central Rd, Arlington Heights, IL 60005 Phone: 847-618-3040 Fax: 847-618-3049 | |
Dr. Jack S. Wu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 800 W Central Rd, Department Of Emergency Medicine, Arlington Heights, IL 60005 Phone: 847-618-3040 Fax: 847-618-3049 |